BioCentury

What BioCentury does

BioCentury Inc. is a privately held, subscription-based B2B intelligence platform serving the global biotechnology industry, founded in 1992 and headquartered in the San Francisco Bay Area. The company provides proprietary analysis, curated structured data, multimedia content, and global networking events targeting biotech and biopharma C-suite executives, venture capital and investment firms, and large pharmaceutical companies that require decision support on deals, regulatory developments, scientific breakthroughs, and competitive dynamics. Named enterprise customers include Takeda, Lundbeckfonden, and Jazz Pharmaceuticals.

The platform is organized around four pillars: BioCentury Analysis (proprietary reporting on product development, deals and finance, politics/policy/law, and discovery/translation), BCIQ Data (a curated database with company, deal, product, target, financial, and IPO profiles plus the Innovation Distillery of 200-word translational briefs on early-stage research), Events (Grand Rounds U.S. and Europe, China Healthcare Summit, East-West Biopharma Summit, Bio€quity Europe), and Workspace (a customizable portal with saved searches and personalized alerts). Supporting products include the BioCentury This Week podcast, The BioCentury Show webcast, webinars, and co-branded white papers.

Revenue is generated primarily through recurring enterprise subscriptions on annual billing, supplemented by event registration, conference and podcast sponsorship packages, and co-branded content partnerships. Customer acquisition is community-led and event-driven, leveraging a global network spanning North America, Europe (UK, Germany, France, Netherlands, Denmark), and Asia (China, Korea, Singapore, Taiwan, Japan, Australia). Leadership includes co-founder, president & CEO David Flores, CTO David Smiling, and Josh Berlin as Head of Global Business Development, Conferences & China/Asia Strategy.

Name

BioCentury

Legal name

BioCentury Inc.

Website

https://biocentury.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

51–100 employees

Short description

BioCentury is a private, subscription-based biotech industry intelligence platform providing proprietary analysis, curated databases, podcasts, and global networking events for biotech executives, investors, and pharmaceutical companies across North America, Europe, and Asia.

Ownership category

akta.pro rank

Product category

Biopharmaceutical Business Intelligence

NAICS

Software Publishers (51321)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

Keywords

• Biopharma intelligence
• Drug development analysis
• Clinical trial data
• Biopharma business intelligence
• Therapeutics industry reporting

Headquarters

HQ city

San Mateo

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Digital Commerce or Content

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Subscription Intelligence Platform: BioCentury operates primarily as a subscription-based B2B intelligence platform providing access to biotech industry analysis, databases (BCIQ), and proprietary content. Subscribers include biotech executives, investors, and pharmaceutical company leaders who pay for comprehensive industry intelligence.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels10 records

Core offering

BioCentury is a subscription-based business-intelligence platform serving the biopharmaceutical industry. It sells editorial analysis, proprietary datasets (BCIQ), an integrated Workspace product, and industry events that together support drug-development, clinical-research, and pharmaceutical-strategy decision-making for biopharma executives and investors.

Product overview

BioCentury offers a unified biotech industry intelligence platform comprising four core pillars: BioCentury® Analysis (proprietary reporting and commentary on industry trends, deals, and regulatory developments), BioCentury® Data/BCIQ (a curated database with company, deal, product, target, and financial profiles plus the Innovation Distillery for early-stage innovations), BioCentury® Events (global conferences including Grand Rounds, China Healthcare Summit, and Bio€quity Europe), and BioCentury® Workspace (personalized portal with custom feeds and alerts). Supporting content products include podcasts (BioCentury This Week, The BioCentury Show), webinars, white papers, and special reports. The BCIQ database integrates all profile types with direct links to BioCentury analyst insights, providing context alongside structured data.

Differentiator

Problem solved

Functional benefit

Brands

• BCIQ: BioCentury's comprehensive Drug Discovery & Development Database providing structured intelligence across biotech and biopharma, including company profiles, deal profiles, product profiles, target profiles, and financial dashboards.
• BioCentury This Week
• The BioCentury Show
• Innovation Distillery
• BioCentury Workspace
• Grand Rounds

Products and services

• BioCentury Analysis Editorial analysis and reporting on biopharmaceutical drug development, clinical trials, regulatory developments, and industry strategy, targeted at biopharma executives and investors.
• BCIQ Data Proprietary structured datasets covering clinical trials, biopharma deals, financings, and regulatory milestones, designed to support competitive intelligence and pipeline analysis.
• BioCentury Workspace Online research environment that integrates BioCentury editorial analysis with the BCIQ datasets and selected third-party data sources, aimed at biopharma analysts and strategists.
• BioCentury Events Industry conferences and convenings for biopharmaceutical executives and investors, supported through tickets and corporate sponsorships.

Quantifiable outcome

• BioCentury covers global biotech deals with comprehensive enrichment and high accuracy through BCIQ database
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Seven partnerships are on record, tiered major and core.

• Daejeon TechnoparkmajorStrategic or Co-development Partner · 11 March 2026BioCentury signed trilateral MOU with Daejeon Technopark and Daejeon Metropolitan Government to establish a channel connecting local Korean biotech companies with global investors and pharmaceutical partners through Biopharma Exchange events.
• Daejeon Metropolitan GovernmentmajorGTM or Marketing Partner · 11 March 2026Partnership positions Daejeon as a global biotech investment hub, supported by the Daejeon Bio Startup Hub scheduled for completion in first half of 2027.
• Korea Biotechnology Industry OrganizationcoreGTM or Marketing Partner · 9 March 2026BioCentury co-hosted the 5th East-West BioPharma Summit (March 9-11, 2026, Seoul) with Korea BIO, featuring Global IR @JPM investor relations presentations connecting Korean biotechs with global investors.
• Sidley AustinmajorGTM or Marketing Partner · 12 January 2026Sidley Austin co-hosted the 6th annual Global IR @JPM event with Korea BIO and BioCentury in San Francisco, connecting 17 global investment firms with 10 domestic and overseas biotech corporations.
• Oppenheimer & Co.majorGTM or Marketing Partner · 25 March 2025BioCentury and Oppenheimer co-presented the Capital Markets Preview webinar discussing how policy changes impact investor sentiment and biotech market outlook, featuring leading investors and KOLs.
• McKinsey & CompanycoreStrategic or Co-development Partner · 1 January 2024McKinsey & Company serves as Insights Partner for multiple BioCentury events including China Healthcare Summit, East-West Biopharma Summit, and produces co-branded white papers on biotech trends, innovation, and market strategies.
• BayHelixcoreStrategic or Co-development Partner · 1 January 2024BayHelix co-presents the East-West Biopharma Summit and China Healthcare Summit with BioCentury, bringing together global executives for cross-border collaboration and innovation discussion.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Endpoints News: Endpoints News is a biotech-focused digital media outlet covering deals, clinical readouts, and industry leadership. It mirrors BioCentury's editorial mission of fact-based, in-depth biotech reporting for executives and investors, and increasingly competes for advertising/sponsorship dollars.
• Evaluate (Norstella): Evaluate provides pharma and biotech commercial intelligence including consensus forecasts, deal data, and product pipelines. It directly overlaps with BioCentury's BCIQ in deal profiling, product profiles, and financial dashboards, serving the same investor and pharma BD personas.
• Citeline (formerly Pharma Intelligence): Citeline (Informa Pharma Intelligence) is the most direct peer, providing clinical trial intelligence, drug development data, and pharma market intelligence to the same biotech executive and investor audience BioCentury serves. Both companies compete for subscriptions covering deals, pipelines, and competitive intelligence.
• Fierce Biotech (Questex): Fierce Biotech is a long-running biotech trade publication providing news, analysis, and event coverage to pharma and biotech professionals. It competes for the same reader attention and marketing budget as BioCentury's editorial and event franchises.

Broad incumbents

• S&P Global Market Intelligence (Capital IQ Pro): S&P Global Market Intelligence offers biotech financial dashboards, M&A data, and competitive intelligence as part of a broad enterprise platform. It competes with BioCentury's Financial Dashboards and is bundled into multi-domain enterprise contracts that BioCentury cannot match.
• GlobalData: GlobalData is a larger intelligence provider with broad coverage across pharma, healthcare, and consumer industries. It offers biotech deal and pipeline data similar to BCIQ but as part of a wider enterprise portfolio, competing on multi-domain enterprise contracts.
• Informa Pharma Intelligence: Informa Pharma Intelligence is the parent of Citeline and a broader portfolio of pharma intelligence brands (Pink Sheet, Scrip, Medtech Insight). It competes with BioCentury across both editorial coverage and data subscriptions at the enterprise level.
• IQVIA: IQVIA is a global healthcare data and analytics incumbent with deep pharma R&D, clinical trial, and commercial intelligence offerings. While not a direct editorial peer, its biotech intelligence modules compete with BCIQ on the enterprise side.
• PitchBook (Morningstar): PitchBook provides private market intelligence including VC deal data that overlaps with BioCentury's deal profiles. While broader than biotech, it serves the same VC and investor customer base and competes for subscription wallet share.

Emerging players

• Crunchbase: Crunchbase provides company, funding, and deal intelligence with increasing depth in biotech. While broader and less biotech-specialized, it competes at the lower-priced end of the deal intelligence market that overlaps with parts of BCIQ.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/biocentury
• YouTubeyoutube.com/@biocenturyvideo487
• LinkedInlinkedin.com/company/biocentury-publications

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioCentury